Method for treating the central nervous system by administration of igf structural analogs

摘要

This invention is directed to a method for treating a disease or disorder of the brain or spinal cord in a mammal, including human, comprising the administration of an effective amount of an insulin-like growth factor (IGF) structural analog at a site outside of the blood-brain, blood-central nervous system, or blood-spinal cord barrier.